MétaCan
Menu
Back to cohort
Record W7117248510 · doi:10.1002/alz70859_096394

Development and Characterization of Small Molecule Chemical Probes for Alzheimer's Disease‐associated Human RNA Helicases

2025· article· en· W7117248510 on OpenAlexaff
U Hang Chan, Fengling Li, Frances M. Bashore, Scott Houliston, Catherine Vu, Irene Chau, Alison D. Axtman, Levon Halabelian

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicRNA Interference and Gene Delivery
Canadian institutionsUniversity Health NetworkStructural Genomics ConsortiumUniversity of Toronto
Fundersnot available
KeywordsSmall moleculeDrug discoveryContext (archaeology)In vitroMDA5Ligand (biochemistry)RNAChemical biology

Abstract

fetched live from OpenAlex

BACKGROUND: To diversify Alzheimer's Disease (AD) drug targets, a bioinformatics core is established to provide an unbiased ranking of AD risk-associated genes by integrating multiple lines of genetic and multi-omic evidence. From which, several RNA helicases, including RIG-I-like receptor 3 (LGP2), melanoma differentiation-associated protein 5 (MDA5) and Dead Box 1 (DDX1) have been identified as high priority targets differentially expressed in AD brains. All three helicases play a role in the innate immune response pathway against viral RNA. Given the previous link between viral infection and AD pathology, this prompted the development of small molecule chemical probe against these targets to further elucidate their roles in AD. METHOD: Purified proteins were used for ATPase assay development and compound screening. The ATPase assay was performed in the presence of annealed 24mer RNA, double-stranded RNA (dsRNA) with a 25-nt 3' overhang, or single-stranded DNA (ssDNA). We employed DNA-encoded chemical library (DEL) and computational methods for small molecule hit discovery. Hit confirmation was carried out by ATPase assay, Surface Plasmon Resonance (SPR), Differential Scanning Fluorimetry (DSF) and 19Fluorine- Nuclear Magnetic Resonance (19F-NMR). Hit expansion was carried out for the most promising hits to increase potency and selectivity. RESULT: We describe the development and optimization of a bioluminescence assay to kinetically characterize the activity of three human RNA helicases involved in innate immune response pathway, including MDA5, LGP2, and DDX1. Through DEL-ML screening, we identified a selective hit for MDA5, and characterized its activity by ATPase assay with IC50 of 8 µM, and orthogonally confirmed by F-NMR. Ongoing studies aim to elucidate the ligand binding site using X-ray crystallography. CONCLUSION: We present a robust high-throughput in vitro assay designed for small molecule screening in a 384-well format, enabling hit optimization and facilitating the discovery of inhibitors for MDA5, LGP2, and DDX1. Through DEL-ML screen, we identified a selective MDA5 inhibitor that can be used to further interrogate its role in AD pathogenesis, and serve as a chemical starting point for future drug discovery efforts. This ligand represents first-in-class small molecule inhibitor for MDA5, a target that has been underexplored in the context of its role in AD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.265
Teacher spread0.242 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicRNA Interference and Gene DeliveryFrench-language works237,207